MS/HP / ANRP ArrêtéArrêté n°000382/MS/HP/ANRP/DG/DVUE
Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.
Arrêté n°000382/MS/HP/ANRP/DG/DVUE is the official MS/HP / ANRP identifier for “Conditions d'octroi d'une autorisation de mise en œuvre d'un essai clinique — dispositions relatives aux DMDIV”. Arrêté n°000382/MS/HP/ANRP/DG/DVUE is the official identifier MS/HP / ANRP uses for this instrument.
- Instrument
- Arrêté
- Full name
- Arrêté n°000382/MS/HP/ANRP/DG/DVUE
- Category
- Clinical Trials
- Source publication
- French
- Readable HTML
- 1 language version
- Published
- —
- Effective
- —
Open a language version
Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.
Conditions d'octroi d'une autorisation de mise en œuvre d'un essai clinique — dispositions relatives aux DMDIV
Selected original physical pages 1, 9 and 10 of a ten-page instrument, signed 22 September 2025. Article 36 expressly requires clinical trials for in vitro diagnostic medical devices and leaves implementation conditions to ANRP. Article 35 provides the clinical-trials committee implemented by Order 570. These selected pages preserve adjacent provisions for context; medicinal experimental-product definitions and requirements are not automatically generalized to all medical devices. All ten original pages were visually read; this is a partial text expression, not a full transcription or a complete IVD application pathway. ANRP's IVD implementation modalities remain unverified.
Arrêté n°000382/MS/HP/ANRP/DG/DVUE is the official identifier MS/HP / ANRP uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.